4 Financial Role Models Who Don't Act Their Age
10 Ways to Snag Amazing Freebies Online
Financial Infidelity Could Doom Your Relationship
Week's Winners and Losers: Starbucks Pops, LeapFrog Flops
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.